arrow
T

Torsten Zuberbier

Charite University Medical Center Berlin
H指数:105
被引数:5.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

As-Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK-air Study

花粉季节过敏性鼻炎治疗中按需用药与常规用药的比较:一项MASK-air研究

2026-09-100
OAAI
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases

ARIA-EAACI 2025:气道疾病中以患者为中心、数字化赋能和人工智能辅助的变革管理

2026-09-030
OAAI
A SynAir-G Position Statement for the Improvement of Indoor Air Quality for Children

SynAir-G 关于改善儿童室内空气质量的立场声明

2026-09-010
OAAI
Efficacy and safety of oral treatments for allergic rhinitis in children: A network meta-analysis

儿童过敏性鼻炎口服治疗的疗效与安全性:一项网络Meta分析

2026-09-010
PRE
World Allergy Organization (WAO) Consensus on the use and practice of precautionary allergen labelling: The international ACT-UP! e-Delphi

世界过敏组织(WAO)关于预防性过敏原标签使用和实施实践的共识:国际ACT-UP! e-Delphi

2026-08-010
PRE
Distinction between allergic rhinitis alone and allergic rhinitis plus asthma in MASK-air ® real-world studies; a ARIA-WAO task force review

MASK-air ®真实世界研究中单纯过敏性鼻炎与过敏性鼻炎合并哮喘的区分;一项ARIA-WAO工作组综述

2026-07-010
OAAI
Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts

全球过敏性鼻炎治疗的可及性与成本:ARIA专家调查

2026-04-180
OAAI
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper

对局部糖皮质激素治疗特应性皮炎及相关皮肤炎症性疾病中反应不足和反应不足的定义:一份GA2LEN ADCARE声明文件

2026-04-150
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第II部分—口服和眼部治疗指南

2026-03-240
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第一部分—关于鼻内治疗的指南

2025-12-010
OAAI
Evaluation of the Quality and Reliability of ChatGPT-4's Responses on Allergen Immunotherapy Using Validated Instruments for Health Information Quality Assessment

使用经过验证的健康信息质量评估工具,对ChatGPT-4在过敏原免疫治疗方面的回答质量和可靠性进行评估。

2025-11-290
OAAI
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms

过敏性鼻炎及其对哮喘的影响(ARIA)-EAACI 2024–2025指南的开发方法:从证据到决策框架到数字化共享决策算法

2025-11-210
OAAI
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
2025-11-150
OAAI
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data

基于移动健康数据,采用目标试验模拟方法评估过敏性鼻炎药物的有效性

2025-11-010
OAAI